Inventor · disambiguated record
John J. Koleng
Also filed as: KOLENG JOHN · KOLENG JOHN J · KOLENG JR JOHN J · KOLENG JR JOHN JOSEPH
28 granted patents·38 pending applications·298 citations·filing 2001–2025
96Inventor score
Files withBODOR LABORATORIES INC18UNIV TEXAS8CROWLEY MICHAEL M4VAUGHN JASON M4AUXILIUM US HOLDINGS LLC3
Top patents by PatentIndex Score
66 records- 0197US11084788B2Formulation for soft anticholinergic analogsBODOR LABORATORIES INC·Filed 2020·Granted Aug 10, 2021·8 cites·19 claims
- 0297US11052067B2Formulation for soft anticholinergic analogsBODOR LABORATORIES INC·Filed 2020·Granted Jul 6, 2021·8 cites·29 claims
- 0397US11034652B2Formulation for soft anticholinergic analogsBODOR LABORATORIES INC·Filed 2020·Granted Jun 15, 2021·8 cites·20 claims
- 0497US6509028B2Methods and compositions for treating pain of the mucous membraneEPICEPT CORP·Filed 2002·Granted Jan 21, 2003·153 cites·31 claims
- 0596US11026919B2Formulation for soft anticholinergic analogsBODOR LABORATORIES INC·Filed 2020·Granted Jun 8, 2021·4 cites·20 claims
- 0694US10961191B2Formulation for soft anticholinergic analogsBODOR LABORATORIES INC·Filed 2019·Granted Mar 30, 2021·9 cites·20 claims
- 0794US8394434B2SCF extract containing cardiac glycosideADDINGTON OTIS CRANDELL·Filed 2012·Granted Mar 12, 2013·31 cites·30 claims
- 0893US11787838B2Modified peptide fragments of CAV-1 protein and the use thereof in the treatment of fibrosisLUNG THERAPEUTICS INC·Filed 2022·Granted Oct 17, 2023·2 cites·27 claims
- 0993US11160869B2Compositions, formulations and interleukin production and purificationAPPLIED MOLECULAR TRANSPORT INC·Filed 2021·Granted Nov 2, 2021·4 cites·25 claims
- 1093US10959983B2Formulation for soft anticholinergic analogsBODOR LABORATORIES INC·Filed 2019·Granted Mar 30, 2021·8 cites·15 claims
- 1193US10947192B2Formulation for soft anticholinergic analogsBODOR LABORATORIES INC·Filed 2019·Granted Mar 16, 2021·8 cites·12 claims
- 1292US12280089B2Dry powder formulation of caveolin-1 peptides and methods of use thereofUNIV TEXAS·Filed 2024·Granted Apr 22, 2025·1 cites·29 claims
- 1392US8173152B2Stabilized compositions containing alkaline labile drugsCROWLEY MICHAEL M·Filed 2007·Granted May 8, 2012·17 cites·11 claims
- 1490US11479593B2Compositions, formulations and interleukin production and purificationAPPLIED MOLECULAR TRANSPORT INC·Filed 2021·Granted Oct 25, 2022·1 cites·30 claims
- 1589US2025041268A1Formulation for soft anticholinergic analogsBODOR LABORATORIES INC·Filed 2024·Application pending·0 cites
- 1688US11123325B2Formulation for soft anticholinergic analogsBODOR LABORATORIES INC·Filed 2017·Granted Sep 21, 2021·4 cites·17 claims
- 1787US10952990B2Formulation for soft anticholinergic analogsBODOR LABORATORIES INC·Filed 2019·Granted Mar 23, 2021·4 cites·14 claims
- 1885US9795559B2Intranasal dexmedetomidine compositions and methods of use thereofRECRO PHARMA INC·Filed 2012·Granted Oct 24, 2017·17 cites·15 claims
- 1983US12280088B2Dry powder formulation of caveolin-1 peptides and methods of use thereofUNIV TEXAS·Filed 2019·Granted Apr 22, 2025·1 cites·18 claims
- 2081US12497431B2Modified peptide fragments of Cav-1 protein and the use thereof in the treatment of fibrosisREIN THERAPEUTICS INC·Filed 2023·Granted Dec 16, 2025·0 cites·27 claims
- 2181US12398102B2Formulation for soft anticholinergic analogsBODOR LABORATORIES INC·Filed 2021·Granted Aug 26, 2025·0 cites·42 claims
- 2281US8883187B2Stabilized compositions containing alkaline labile drugsCROWLEY MICHAEL M·Filed 2012·Granted Nov 11, 2014·2 cites·16 claims
- 2380US11905336B2Modified peptide fragments of CAV-1 protein and the use thereof in the treatment of fibrosisLUNG THERAPEUTICS INC·Filed 2019·Granted Feb 20, 2024·1 cites·11 claims
- 2479US12156865B2Formulation for soft anticholinergic analogsBODOR LABORATORIES INC·Filed 2021·Granted Dec 3, 2024·0 cites·22 claims
- 2579US10682311B2Intranasal dexmedetomidine compositions and methods of use thereofBAUDAX BIO INC·Filed 2017·Granted Jun 16, 2020·2 cites·16 claims
- 2678US9364445B2Stabilized compositions containing alkaline labile drugsAUXILIUM US HOLDINGS LLC·Filed 2014·Granted Jun 14, 2016·1 cites·15 claims
- 2777US9867786B2Stabilized compositions containing alkaline labile drugsAUXILIUM US HOLDINGS LLC·Filed 2016·Granted Jan 16, 2018·1 cites·12 claims
- 2874US12357609B2Formulation for soft anticholinergic analogsBODOR LABORATORIES INC·Filed 2021·Granted Jul 15, 2025·0 cites·19 claims
- 2973US8465759B2Process for the preparation of a hot-melt extruded laminateCROWLEY MICHAEL M·Filed 2007·Granted Jun 18, 2013·3 cites·16 claims
- 3071US2008075771A1Hydrophilic opioid abuse deterrent delivery system using opioid antagonistsVAUGHN JASON M·Filed 2007·Application pending·0 cites
- 3171US2008075770A1Hydrophilic abuse deterrent delivery systemVAUGHN JASON M·Filed 2007·Application pending·0 cites
- 3270US2015259283A1Formulation for soft anticholinergic analogsBRICKELL BIOTECH INC·Filed 2014·Application pending·0 cites
- 3370US2018228770A1Formulation for soft anticholinergic analogsBODOR LABORATORIES INC·Filed 2016·Application pending·0 cites
- 3469US2025302910A1Dry powder formulation of caveolin-1 peptides and methods of use thereofUNIV TEXAS·Filed 2025·Application pending·0 cites
- 3568US2017020845A1Formulation for soft anticholinergic analogsBODOR LABORATORIES INC·Filed 2015·Application pending·0 cites
- 3667US2010047345A1Hydrophobic abuse deterrent delivery system for hydromorphoneCROWLEY MICHAEL M·Filed 2009·Application pending·0 cites
- 3762US2008020032A1Hydrophobic abuse deterrent delivery system for hydromorphoneCROWLEY MICHAEL·Filed 2007·Application pending·0 cites
- 3862US2018021300A1Formulation for soft anticholinergic analogsBODOR LABORATORIES INC·Filed 2017·Application pending·0 cites
- 3962US2008075768A1Hydrophobic opioid abuse deterrent delivery system using opioid antagonistsVAUGHN JASON M·Filed 2007·Application pending·0 cites
- 4062US2008069871A1Hydrophobic abuse deterrent delivery systemVAUGHN JASON M·Filed 2007·Application pending·0 cites
- 4162US2015320722A1Formulation for soft anticholinergic analogsBODOR LAB INC·Filed 2015·Application pending·0 cites
- 4260US2025346558A1Formulation for soft anticholinergic analogsBODOR LABORATORIES INC·Filed 2025·Application pending·0 cites
- 4360US2023190735A1Compositions comprising voriconazole inhalation powder and methods of manufacture and use thereofTFF PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4459US2022362222A1Once daily formulations of tacrolimusTFF PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4558US2023288116A1Large scale synthesis of pharmaceutical and biologic formulations using thin film freezingTFF PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4658US2023112800A1Delayed release niclosamide formulationUNIV TEXAS·Filed 2022·Application pending·0 cites
- 4757US2025295630A1Formulation for soft anticholinergic analogsBODOR LABORATORIES INC·Filed 2025·Application pending·0 cites
- 4855US2022168465A1Biodegradable nasal splintSEPTUM SOLUTIONS LLC·Filed 2020·Application pending·0 cites
- 4954US2022313611A1Methods to prepare dry powders using suspension based thin film freezingUNIV TEXAS·Filed 2022·Application pending·0 cites
- 5054US2013259920A1Process for the preparation of a hot-melt extruded laminateAUXILIUM US HOLDINGS LLC·Filed 2013·Application pending·0 cites
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John J. Koleng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →